This inventor holds 1 USPTO granted patent. Top assignee: National Institute of Health and Medical Research. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Claude Mawas: Innovator in Graft Failure Treatment
Introduction
Claude Mawas is a notable inventor based in Marseille, France. He has made significant contributions to the field of medical research, particularly in the area of graft failure treatment. His innovative approach has the potential to improve patient outcomes in critical medical situations.
Latest Patents
Mawas holds a patent for a method aimed at preventing and treating graft failure in human patients. This invention involves the injection of a specific anti-LFA-1 monoclonal antibody, which is designed to enhance the success rates of graft procedures. His patent is a testament to his commitment to advancing medical science and improving patient care. He has 1 patent to his name.
Career Highlights
Claude Mawas is affiliated with the National Institute of Health and Medical Research, where he conducts his research and develops innovative medical solutions. His work has garnered attention for its potential impact on transplant medicine and patient recovery.
Collaborations
Mawas has collaborated with esteemed colleagues in his field, including Daniel Olive and Claude Griscelli. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medical research.
Conclusion
Claude Mawas is a pioneering inventor whose work in graft failure treatment exemplifies the intersection of innovation and healthcare. His contributions are vital to the ongoing efforts to enhance medical procedures and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile